| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |